Type-1 Collagen differentially alters beta-catenin accumulation in primary Dupuytren's Disease cord and adjacent palmar fascia cells.

Full Abstract

BACKGROUND: Dupuytren's Disease (DD) is a debilitating contractile fibrosis of the palmar fascia characterised by excess collagen deposition, contractile myofibroblast development, increased transforming growth factor-beta levels and beta-catenin accumulation. The aim of this study was to determine if a collagen-enriched environment, similar to in vivo conditions, altered beta-catenin accumulation by primary DD cells in the presence or absence of transforming growth factor-beta. METHODS: Primary DD and patient matched, phenotypically normal palmar fascia (PF) cells were cultured in the presence or absence of type-1 collagen and transforming growth factor-beta1. beta-catenin and alpha-smooth muscle actin levels were assessed by western immunoblotting and immunofluorescence microscopy. RESULTS: DD cells display a rapid depletion of cellular beta-catenin not evident in patient-matched PF cells. This effect was not evident in either cell type when cultured in the absence of type-1 collagen. Exogenous addition of transforming growth factor-beta1 to DD cells in collagen culture negates the loss of beta-catenin accumulation. Transforming growth factor-beta1-induced alpha-smooth muscle actin, a marker of myofibroblast differentiation, is attenuated by the inclusion of type-1 collagen in cultures of DD and PF cells. CONCLUSION: Our findings implicate type-1 collagen as a previously unrecognized regulator of beta-catenin accumulation and a modifier of TGF-beta1 signaling specifically in primary DD cells. These data have implications for current treatment modalities as well as the design of in vitro models for research into the molecular mechanisms of DD.

Author information

Author/s: Vi, Linda (L); Njarlangattil, Anna (A); Wu, Yan (Y); Gan, Bing Siang (BS); O'Gorman, David B (DB);

Affiliation: Cell and Molecular Biology Laboratory, Hand and Upper Limb Centre, Lawson Health Research Institute, London, Canada. lvi(-atsign-)uwo.ca

Journal and publication information

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal: BMC musculoskeletal disorders (BMC Musculoskelet Disord), published in England. (Language: eng)

Reference: 2009-; vol 10 (issue ) : pp 72

Dates: Created 2009/07/28; Completed 2009/09/24;

PMID: 19545383, status: MEDLINE (last retrieval date: 9/24/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Actins - metabolism
Case-Control Studies
Cells, Cultured
Collagen Type I - metabolism
Dupuytren's Contracture - metabolism; pathology
Fascia - metabolism; pathology

Fascia - metabolism; pathology
Humans
Recombinant Proteins - metabolism
Time Factors
Transforming Growth Factor beta1 - metabolism
beta Catenin - metabolism

Associated Chemicals: Actins (0) ; CTNNB1 protein, human (0) ; Collagen Type I (0) ; Recombinant Proteins (0) ; Transforming Growth Factor beta1 (0) ; beta Catenin (0)

These are the highest related articles currently in the database: